Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel.
This study aimed to evaluate whether and how the internal structure and composition of liquid crystalline systems can be tailored to maximize paclitaxel cutaneous delivery. Liquid crystalline phases of water, Brij-97, and medium-chain mono/diglycerides (MCG) were characterized by polarized light microscopy. Lamellar phases containing 20% (w/w) water and MCG at 10% (LP-10) or 20% (LP-20), and a hexagonal phase (HP) with 45% water and 10% MCG were selected; paclitaxel was incorporated at 0.5% (w/w). Compared with drug solution in myvacet oil, LP-20 provided the highest paclitaxel cutaneous delivery (threefold), and LP-10 the highest transdermal delivery (fourfold). Using a fluorescent drug derivative [at 0.5%, (w/w)], we observed that penetration occurred through intact stratum corneum. To evaluate whether penetration results relate to drug release differences, paclitaxel self-diffusion coefficient (D) and in vitro release were studied. D was the highest in LP-20, but release from LP-20 and LP-10 was similar. The low D in HP was associated with the lowest drug release. As an index of efficacy, we assessed the cytotoxicity of paclitaxel-loaded LP-20 against fibroblasts. Cell viability was 1.3-2 times smaller with LP-20 than with drug solution. Our results demonstrate that LP-20 provides optimization of paclitaxel cutaneous delivery and efficient cytotoxicity.
Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Albany, New York 12208.
Jaclyn M
JM
Hosmer
Soo H
SH
Shin
Adwoa
A
Nornoo
Haian
H
Zheng
Luciana B
LB
Lopes
D000279:Administration, Cutaneous; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005989:Glycerides / Q000737:chemistry; D050866:Liquid Crystals / Q000737:chemistry*; D017239:Paclitaxel / Q000008:administration & dosage* / Q000493:pharmacokinetics; D014677:Pharmaceutical Vehicles / Q000737:chemistry*; D044367:Phase Transition; D010938:Plant Oils / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D013552:Swine; D014867:Water / Q000737:chemistry
D000972:Antineoplastic Agents, Phytogenic; D005989:Glycerides; D014677:Pharmaceutical Vehicles; D010938:Plant Oils; D014867:Water; D011092:Polyethylene Glycols; C033084:polyethylene glycol oleyl ether; D017239:Paclitaxel